載入...
Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia
Achondroplasia (ACH) is the most common short-limbed skeletal dysplasia caused by gain-of-function mutations in the fibroblast growth factor receptor 3 (FGFR3). No effective FGFR3-targeted therapies for ACH are currently available. By drug repositioning strategies, we identified that meclozine, whic...
Na minha lista:
| 發表在: | Sci Rep |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5547068/ https://ncbi.nlm.nih.gov/pubmed/28785080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-07044-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|